Immune response and catching Covid twice

Immune response and catching Covid twice

The Lindsley F. Kimball Research Institute of the New York Blood Centre and Rockefeller University in June concluded that herd immunity is not as simple as it sounds but that antibody testing retains a key role in localised lockdowns....

Continue reading →

Old drugs plus SARS equals new INDs and M&A pressure wave

Old drugs plus SARS equals new INDs and M&A pressure wave

There is pressure for M&A and raised valuation multiples in the kinase inhibitor market. The University of California San Francisco (UCSF) conducted a research study in April 2020 that took existing and approved drugs and investigated their ability to stop...

Continue reading →

Trump’s 4 Exec Orders to lower drugs prices and save $17bn – not what it seems

Trump’s 4 Exec Orders to lower drugs prices and save $17bn – not what it seems

US President Trump signed four executive orders on the 24th July 2020 aimed at lowering drug prices and setting an International Price Index (IPI) for drugs. While the Covid-19 pandemic has muted calls for drug price reductions over the...

Continue reading →